Published In
BJM Open
Document Type
Article
Publication Date
2020
Subjects
Communication in medicine, Immunization of children
Abstract
Introduction A key contributor to under immunisation is parental refusal or delay of vaccines due to vaccine concerns. Many clinicians lack confidence in communicating with vaccine-hesitant parents (VHP) and perceive that their discussions will do little to change parents’ minds. Improving clinician communication with VHPs is critical to increasing childhood vaccine uptake.
Methods and analysis We describe the protocol for a cluster randomised controlled trial to test the impact of a novel, multifaceted clinician vaccine communication strategy on child immunisation status. The trial will be conducted in 24 primary care practices in two US states (Washington and Colorado). The strategy is called Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing (PIVOT with MI), and involves clinicians initiating the vaccine conversation with all parents of young children using the presumptive format, and among those parents who resist vaccines, pivoting to using MI. Our primary outcome is the immunisation status of children of VHPs at 19 months, 0 day of age expressed as the percentage of days underimmunised from birth to 19 months for 22 doses of eight vaccines recommended during this interval. Secondary outcomes include clinician experience communicating with VHPs, parent visit experience and clinician adherence to the PIVOT with MI communication strategy.
Rights
Copyright (c) 2020 The Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
Locate the Document
DOI
10.1136/bmjopen-2020-039299
Persistent Identifier
https://archives.pdx.edu/ds/psu/33771
Citation Details
Opel, D. J., Robinson, J. D., Spielvogle, H., Spina, C., Garrett, K., Dempsey, A. F., ... & Taylor, J. A. (2020). ‘Presumptively Initiating Vaccines and Optimizing Talk with Motivational Interviewing’(PIVOT with MI) trial: a protocol for a cluster randomised controlled trial of a clinician vaccine communication intervention. BMJ open, 10(8), e039299.